iZafe Group AB (publ.) announced that the company has signed a cooperation agreement with MDM Pulse for the right to sell and market the pharmaceutical robot Dosell in Portugal. MDM Pulse's minimum commitment over a five-year period amounts to SEK 12.2 million to subsequently generate a recurring license income of at least SEK 4.2 million annually.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.238 SEK | +6.25% |
|
-0.83% | -17.36% |
Jul. 03 | Izafe Group AB Receives Confirms Order of 500 Dosell Units from Ti Medi | CI |
Apr. 26 | IZafe Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-17.36% | 6.23M | |
+3.26% | 209B | |
+6.55% | 183B | |
+31.66% | 158B | |
+34.32% | 114B | |
+5.13% | 67.29B | |
+19.33% | 54.83B | |
-3.30% | 46.88B | |
-4.84% | 38.58B | |
+3.83% | 36.65B |
- Stock Market
- Equities
- IZAFE B Stock
- News iZafe Group AB
- IZafe Group AB (publ.) Signs Agreement with New Partner in Portugal with Value of at Least SEK 12.2 Million